Holen Sie sich die Stockscreener-App
13.89
6.98%
-0.86
Handel nachbörslich:
13.89
Schlusskurs vom Vortag:
$14.75
Offen:
$14.58
24-Stunden-Volumen:
22,882
Relative Volume:
0.31
Marktkapitalisierung:
$172.69M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-31.48M
KGV:
-13.36
EPS:
-1.04
Netto-Cashflow:
$-28.71M
1W Leistung:
-3.58%
1M Leistung:
+29.92%
6M Leistung:
+145.44%
1J Leistung:
+188.84%
1-Tages-Spanne:
$13.68
$14.65
1-Wochen-Bereich:
$13.68
$15.50
52-Wochen-Spanne:
$4.11
$28.68
Forte Biosciences Inc Stock (FBRX) Company Profile
Firmenname
Forte Biosciences Inc
Sektor
Branche
Telefon
(310) 618-6994
Adresse
3060 PEGASUS PARK DRIVE, DALLAS, CA
Vergleichen Sie FBRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FBRX
Forte Biosciences Inc
|
13.89 | 183.38M | 0 | -31.48M | -28.71M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-18 | Eingeleitet | Guggenheim | Buy |
| 2025-01-21 | Eingeleitet | TD Cowen | Buy |
| 2024-04-08 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2021-09-20 | Hochstufung | Chardan Capital Markets | Sell → Buy |
| 2021-09-03 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2021-09-03 | Herabstufung | Chardan Capital Markets | Buy → Sell |
| 2021-09-03 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2021-09-03 | Herabstufung | Truist | Buy → Hold |
| 2021-05-14 | Eingeleitet | B. Riley Securities | Buy |
| 2021-03-26 | Eingeleitet | Citigroup | Buy |
| 2020-08-28 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2020-08-25 | Eingeleitet | Truist | Buy |
Alle ansehen
Forte Biosciences Inc Aktie (FBRX) Neueste Nachrichten
How to read the order book for Forte Biosciences Inc.Fed Meeting & Weekly Momentum Picks - newser.com
Forte Biosciences Inc. stock retracement – recovery analysisBreakout Watch & Technical Entry and Exit Tips - newser.com
Is Forte Biosciences Inc. building a consolidation baseEarnings Recap Report & Low Risk Profit Maximizing Plans - newser.com
How Forte Biosciences Inc. stock performs in rate cut cyclesWatch List & Real-Time Buy Signal Alerts - newser.com
Institutional scanner results for Forte Biosciences Inc.Rate Cut & Verified Momentum Watchlists - newser.com
How Forte Biosciences Inc. stock performs in interest rate cyclesWeekly Market Report & High Accuracy Investment Signals - newser.com
Why Forte Biosciences Inc. stock is a value investor pick2025 Price Momentum & Scalable Portfolio Growth Ideas - newser.com
Forecasting Forte Biosciences Inc. price range with options data2025 Support & Resistance & Safe Entry Zone Tips - newser.com
What institutional flow reveals about Forte Biosciences Inc.GDP Growth & Daily Entry Point Trade Alerts - newser.com
Is Forte Biosciences Inc. stock entering bullish territoryPortfolio Profit Report & Fast Gain Swing Alerts - newser.com
Forte Biosciences Inc. stock prediction for this weekGap Down & Comprehensive Market Scan Reports - newser.com
Chart based analysis of Forte Biosciences Inc. trendsOil Prices & AI Driven Price Forecasts - newser.com
What makes Forte Biosciences Inc. (37T) stock appealing to growth investors2025 Market Trends & Real-Time Buy Zone Alerts - newser.com
Forte Biosciences (NASDAQ:FBRX) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat
Forte Biosciences Inc. Reports Inducement Grants Under Nasdaq Listing Rules - MarketScreener
Can a trend reversal in Forte Biosciences Inc. lead to recoveryTrend Reversal & Weekly High Conviction Ideas - newser.com
Will Forte Biosciences Inc. continue its uptrendDollar Strength & Fast Moving Stock Trade Plans - newser.com
Forte Biosciences reports inducement grants under Nasdaq listing rules - MarketScreener
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules - MarketScreener
Will Forte Biosciences Inc. (37T) stock outperform Dow JonesTrade Performance Summary & Free Low Drawdown Momentum Trade Ideas - newser.com
Forte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX) - MarketBeat
How to build a dashboard for Forte Biosciences Inc. stock2025 Technical Overview & Accurate Entry and Exit Point Alerts - newser.com
Forte Biosciences (FBRX) Price Target Increased by 16.98% to 53.30 - Nasdaq
What to do if you’re stuck in Forte Biosciences Inc.2025 Institutional Moves & Long Hold Capital Preservation Plans - newser.com
Finanzdaten der Forte Biosciences Inc-Aktie (FBRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Forte Biosciences Inc-Aktie (FBRX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Wagner Paul A. | SEE REMARKS |
Oct 01 '25 |
Option Exercise |
0.00 |
1,250 |
0 |
82,190 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Jul 01 '25 |
Option Exercise |
0.00 |
375 |
0 |
31,733 |
| Wagner Paul A. | SEE REMARKS |
Jul 01 '25 |
Option Exercise |
0.00 |
1,250 |
0 |
81,038 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Apr 01 '25 |
Option Exercise |
0.00 |
375 |
0 |
31,372 |
| Wagner Paul A. | SEE REMARKS |
Apr 01 '25 |
Option Exercise |
0.00 |
1,250 |
0 |
79,806 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Jan 01 '25 |
Option Exercise |
0.00 |
375 |
0 |
31,151 |
| Wagner Paul A. | SEE REMARKS |
Jan 01 '25 |
Option Exercise |
0.00 |
1,250 |
0 |
78,720 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Nov 21 '24 |
Buy |
5.55 |
22,514 |
124,998 |
30,776 |
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):